Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure
February 18, 2016 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) shares the hemp innovator’s vision and...